© 1990 Oxford University Press
other |
Nitrat biosynthesis in rats, ferrets and humans. Precursor studies with L-arginine
1Division of Toxicology, Whitaker College Cambridge, MA 02139, USA
2Department of Chemistry Cambridge, MA 02139, USA
3Division of Comparative Mcdicine, Massachusetts Institute of Technology. Cambridge, MA 02139, USA
4To whom correspondence should be addressed
L-Arglnine, the primary nitrogen source for nitric oxide synthesized by many cell types in culture and for bio-synthesized nitrate in humans, is also a nitrogen source for biosynthesized nitrate in rats and ferrets. After administration of [15N2]L-arginine to rats and ferrets, [15N]NO3 was detected in urine. Escherichia coli lipopolysaccharide induced more than a 10-fold increase in urinary nitrate in rats and a parallel increase in incorporation of 15N from [15N2]L-arginine into NO3. Bradykinin, a vasodilator which induces nitric oxide production by endothelial cells in vitro, lacked detectable effect on urinary nitrate or on incorporation of L-arginine nitrogen into nitrate in rats. A prolonged period of vasodilation brought on by an extended period of exercise increased urinary nitrate 2-fold in human subjects. In the rat, recoveries in 24 h post-dose urine collections of [15N]NO3 given i.v. and i.p. were 75 and 64% respectively, while in the ferret, recoveries of i.v. and per os [15N]NO3 doses were 49 and 34% respectively. Thus, nitrate synthesized by mammalian cells in vivo would undergo losses similar to those for exogenous nitrate.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Meini, A. Benocci, M. Frosini, G. Sgaragli, G. Pessina, C. Aldinucci, G. T. Youmbi, and M. Palmi Nitric Oxide Modulation of Interleukin-1{beta}-Evoked Intracellular Ca2+ Release in Human Astrocytoma U-373 MG Cells and Brain Striatal Slices J. Neurosci., December 15, 2000; 20(24): 8980 - 8986. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Katz, T. Khan, G. A. Zeballos, L. Mathew, P. Potharlanka, M. Knecht, and J. Whelan Decreased Activity of the L-Arginine–Nitric Oxide Metabolic Pathway in Patients With Congestive Heart Failure Circulation, April 27, 1999; 99(16): 2113 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. M. Avontuur, F. Boomsma, A. H. van den Meiracker, F. H. de Jong, and H. A. Bruining Endothelin-1 and Blood Pressure After Inhibition of Nitric Oxide Synthesis in Human Septic Shock Circulation, January 19, 1999; 99(2): 271 - 275. [Abstract] [Full Text] [PDF] |
||||

